Next report date
Report period
Q1 2024
EPS estimate
−0.10USD
Revenue estimate
193.51 MUSD
−3.2USD
−263.30 MUSD
753.20 MUSD
86.02 M
About Myriad Genetics, Inc.
Sector
Industry
CEO
Paul J. Diaz
Website
Headquarters
Salt Lake City
Employees (FY)
2.7 K
Founded
1991
FIGI
BBG00JVRFJC3
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0K3W is 18.0 USD — it has decreased by 3.49% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MYRIAD GENETICS INC COM USD0.01 stocks are traded under the ticker 0K3W.
MYRIAD GENETICS INC COM USD0.01 is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
0K3W stock is 3.61% volatile and has beta coefficient of 2.43. Check out the list of the most volatile stocks — is MYRIAD GENETICS INC COM USD0.01 there?
0K3W earnings for the last quarter are −0.03 USD per share, whereas the estimation was −0.08 USD resulting in a 60.29% surprise. The estimated earnings for the next quarter are 0.01 USD per share. See more details about MYRIAD GENETICS INC COM USD0.01 earnings.
MYRIAD GENETICS INC COM USD0.01 revenue for the last quarter amounts to 191.90 M USD despite the estimated figure of 182.32 M USD. In the next quarter revenue is expected to reach 194.80 M USD.
Yes, you can track MYRIAD GENETICS INC COM USD0.01 financials in yearly and quarterly reports right on TradingView.
0K3W stock has fallen by 4.26% compared to the previous week, the month change is a 18.74% fall, over the last year MYRIAD GENETICS INC COM USD0.01 has showed a 15.21% decrease.
0K3W net income for the last quarter is −31.20 M USD, while the quarter before that showed −61.30 M USD of net income which accounts for 49.10% change. Track more MYRIAD GENETICS INC COM USD0.01 financial stats to get the full picture.
Today MYRIAD GENETICS INC COM USD0.01 has the market capitalization of 1.63 B, it has decreased by 2.27% over the last week.
No, 0K3W doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0K3W shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYRIAD GENETICS INC COM USD0.01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 2.70 K employees. See our rating of the largest employees — is MYRIAD GENETICS INC COM USD0.01 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYRIAD GENETICS INC COM USD0.01 technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYRIAD GENETICS INC COM USD0.01 stock shows the sell signal. See more of MYRIAD GENETICS INC COM USD0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MYRIAD GENETICS INC COM USD0.01 future price: according to them, 0K3W price has a max estimate of 31.00 USD and a min estimate of 12.00 USD. Read a more detailed MYRIAD GENETICS INC COM USD0.01 forecast: see what analysts think of MYRIAD GENETICS INC COM USD0.01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MYRIAD GENETICS INC COM USD0.01 EBITDA is −75.10 M USD, and current EBITDA margin is −9.48%. See more stats in MYRIAD GENETICS INC COM USD0.01 financial statements.